Table 2

Proportion of recurrent parasitaemia and treatment failures at 28 days after treatment, Kindamba, ROC, 2004

AS + AQ
 AS + SP
 AL
 χ2

n
 %
 95% CI
 n
 %
 95% CI
 n
 %
 95% CI
 P
No PCR
 97

85

100


     ACPR
 66
 68.0
 57.8–77.1
 64
 75.3
 64.7–84.0
 87
 87.0
 78.8–92.9
 0.006
Parasites/fever
 19
 19.6
 12.2–28.9
 9
 10.6
 5.0–19.1
 5
 5.0
 1.6–11.3
Parasites/no fever
 12
 12.4
 6.6–20.6
 12
 14.1
 7.5–23.4
 8
 8.0
 3.5–15.2
Recurrent parasitaemia
 31
 32.0
 22.9–42.2
 21
 24.7
 16.0–35.3
 13
 13.0
 7.1–21.2
 0.006
PCR adjusted
 67

71

87


     ACPR
 66
 98.5
 92.0–100
 64
 90.1
 80.7–95.9
 87
 100.0
 95.8–100
 0.003
     LCF
 0
 0.0
 0–5.4
 2
 2.8
 0.3–9.8
 0
 0.0
 0–4.2
     LPF
 1
 1.5
 0–8.0
 5
 7.0
 2.3–15.7
 0
 0.0
 0–4.2
Treatment failure
 1
 1.5
 0.0–8.0
 7
 9.9
 19.3–4.1
 0
 0.0
 0.0–5.2
 0.003

van den Broek et al. Malaria Journal 2006 5:113   doi:10.1186/1475-2875-5-113